Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
2(18%)
Results Posted
33%(1 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_3
1
9%
Ph phase_1
1
9%
Ph not_applicable
3
27%
Ph phase_2
4
36%

Phase Distribution

1

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(3)
Terminated(3)
Other(3)

Detailed Status

Completed3
Terminated3
unknown3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 24 (44.4%)
Phase 31 (11.1%)
N/A3 (33.3%)

Trials by Status

completed327%
terminated327%
recruiting218%
unknown327%

Recent Activity

2 active trials
Showing 5 of 11
recruitingphase_1

Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)

NCT07317609
terminatedphase_2

Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer

NCT05161572
completednot_applicable

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)

NCT02072148
recruitingnot_applicable

Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer

NCT05378087
unknown

Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer

NCT04809844
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07317609Phase 1

Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)

Recruiting
NCT05161572Phase 2

Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer

Terminated
NCT02072148Not Applicable

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)

Completed
NCT05378087Not Applicable

Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer

Recruiting
NCT04809844

Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer

Unknown
NCT05232552Phase 2

Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma

Unknown
NCT02636556Not Applicable

Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors

Completed
NCT00325871

Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer

Completed
NCT01674959Phase 2

Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients

Unknown
NCT01667289Phase 2

Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma

Terminated
NCT00128817Phase 3

Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers

Terminated

All 11 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
11